Tympanogen

Tympanogen, Inc.

33 Investors
Medical Devices
RICHMOND, VA

Tympanogen, Inc. is a cutting-edge medical device company focused on developing innovative solutions for ear, nose, and throat (ENT) procedures. Their primary aim is to simplify the treatment process for eardrum perforations, providing a more efficient alternative to traditional surgical methods.

Products & Team

Perf-Fix™

Medical DeviceSeed

Perf-Fix™ is a novel gel patch specifically designed for the repair of eardrum perforations. This innovative product allows for a straightforward application by healthcare professionals in an outpatient setting without the need for surgery.

Value Proposition

Perf-Fix™ addresses the significant drawbacks of conventional eardrum repair surgery, such as invasiveness, high costs, and prolonged recovery periods, providing an accessible and efficient alternative.

Pain Points

Tympanogen specifically targets the challenges of invasive surgical repairs, such as high costs, lengthy recovery times, and the risks associated with anesthesia.

Non-invasive applicationQuick procedure that can be completed in a clinic visitEliminates the need for general anesthesiaMinimizes recovery time compared to traditional tympanoplasty
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
RICHMOND, VA
Primary headquarters

Funding History

Total Raised:
$1.2M
E

Equity Offering

February 2025
$5.0M
Target
Progress
23%
Raised
$1.2M
Target
$5.0M
#000205957225000002